A phase I trial of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-schedule.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples